Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Microfollicles can effectively model human hair follicles for research and testing.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.

Researchers created a mouse cell line to study hair growth and test hair growth drugs.

The 3D hair follicle model improves understanding of hair growth and drug testing.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Some children in Malaysia with symptoms have either profound or partial biotinidase deficiency, and early testing and treatment are important.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Researchers developed a 3D model of human hair follicle cells that can help understand hair growth and test new hair loss treatments.